|Market Size in 2022||Market Forecast in 2028||CAGR (in %)||Base Year|
|USD 2800 Million||USD 4600 Million||6.5%||2022|
Angular Cheilitis Treatment Market
The global Angular Cheilitis Treatment market size was worth around USD 2800 million in 2022 and is predicted to grow to around USD 4600 million by 2030 with a compound annual growth rate (CAGR) of roughly 6.5% between 2023 and 2030.
The report analyzes the global Angular Cheilitis Treatment market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the angular cheilitis treatment industry.
An inflammation-related disorder that commonly affects the corners of the mouth or oral commissures is called angular cheilitis. It is also referred to as perleche (perlèche), cheilosis, angular stomatitis, and rhagades. At the angles of the mouth, where two different kinds of skin lining converge and serve as a hinge, angular cheilitis develops. Squamous epithelium (facial skin) meets oral mucosa, the lining of the mouth cavity. They are susceptible to stress and damage since they are frequently used for eating, drinking, and conversing. The most frequent cause of angular cheilitis is eczematous cheilitis, a kind of irritating contact dermatitis, which develops when the corners of the mouth are exposed to saliva and its digestive enzymes for an extended period. The angular cheilitis treatment market is being driven by various factors including the growing prevalence of diabetes, rising cases of angular cheilitis, and growing R&D investment.
The increasing prevalence of angular cheilitis along with the rising elderly population drives the market growth
The increasing prevalence of angular cheilitis along with the rising elderly population is expected to drive the global angular cheilitis treatment market growth over the forecast period. For instance, an estimated 0.7% of people in the population suffer from angular cheilitis, making it a moderately common condition. Children also experience it rather frequently and those in their 30s to 60s are most likely to do so. According to a 2014 study, there were 2.5 cases of herpes labialis and 1.9 cases of angular cheilitis per 1,000 people.
In addition, the elderly population is more prone to these conditions due to digestive issues. Thus, the growing elderly population is another major prospect that propels the market expansion. According to the World Health Organization, One in six individuals on the planet will be 60 or older by 2030. By this point, there will be 1.4 billion people over the age of 60, up from 1 billion in 2020. The number of individuals in the world who are 60 or older will double (to 2.1 billion) by 2050. Between 2020 and 2050, the number of people 80 or older is projected to treble, reaching 426 million.
Preference for home remedies hamper the market growth
Some people may choose to treat Angular Cheilitis using home remedies or over-the-counter products rather than seeking medical intervention. Numerous products in home remedies will treat these conditions including aloe vera gel, honey, virgin coconut oil, baking soda, cucumber, cocoa butter, and others. Therefore, the preference for home remedies over pharmaceutical treatment is expected to hamper the angular cheilitis treatment industry growth during the forecast period.
The increasing prevalence of diabetes offers a significant opportunity
The increasing prevalence of diabetes is expected to offer a significant opportunity for angular cheilitis treatment market growth over the forecast period. According to the CDC figures given in 2022, 11.3% of Americans, or 37.3 million individuals, have diabetes. 28.5% of the population, or an estimated 28.7 million individuals, had diabetes. There are around 8.5 million diabetics who have not yet received a diagnosis. It has been shown that patients with diabetes are far more susceptible to fungal infections such as angular cheilitis. A surplus of glucose in the body might encourage the growth of fungus. Diabetes also weakens the immune system, making it more difficult for the body to fight off infections. Thus, this factor is expected to provide a lucrative opportunity for market growth during the forecast period.
The lack of specific treatments and side effects poses a major challenge to the market growth
Angular Cheilitis frequently has underlying causes such as dietary deficits, bacterial or fungal infections, or other systemic ailments. The effectiveness of existing therapies may be constrained by the absence of specialized remedies that address the underlying cause. In addition, some topical treatments may cause skin irritation or allergic reactions in certain individuals. Thus, the lack of specific treatments and side effects poses a major challenge for the market growth over the forecast period.
The global Angular Cheilitis Treatment industry is segmented based on diagnosis, treatment, end user, distribution channel, and region.
Based on the diagnosis, the global market is bifurcated into physical examination and others. The physical examination segment is expected to hold the largest angular cheilitis treatment market share over the forecast period. A comprehensive physical examination by a medical specialist, such as a dermatologist or primary care doctor, is often required to diagnose angular cheilitis. The healthcare provider will assess whether the condition is affecting one or both corners of the mouth, as this can provide important diagnostic clues. Since Angular Cheilitis can be linked to various underlying causes, the healthcare provider may inquire about nutritional habits, dental health, oral hygiene, and any signs of infection. Thus, this is expected to drive the segment growth over the forecast period.
Based on the treatment, the global Angular Cheilitis Treatment industry is divided into antifungal, antibiotics, antiseptics, steroids, botulinum toxin, and others. The antibiotics segment is expected to capture a significant portion of the market share over the forecast period. When there is evidence that a bacterial infection is causing the Angular Cheilitis, antibiotics may occasionally be used as a therapy. Bacterial infections can make the mouth's irritation and corner cracking severe. Antibiotics are used to combat certain bacterial diseases, decrease infection, and speed up the healing process. Besides, the antiseptics segment is expected to grow at the fastest CAGR during the forecast period. Antiseptics can be applied to clean the affected area and reduce the risk of secondary bacterial infection, especially when the skin is cracked and vulnerable to microbial colonization. In some cases, antiseptics may be used in conjunction with other treatment modalities to prevent or treat secondary infections. Thereby, driving the segment growth over the forecast period.
Based on end-user, the market is segmented into hospitals, homecare, specialty clinics, and others. The specialty clinics segment is expected to garner the largest revenue share of the market over the projected period. The diagnosis and management of Angular Cheilitis are mostly dependent on specialty clinics, notably dermatology clinics. Skin diseases, such as Angular Cheilitis, are diagnosed and treated at dermatology clinics, which are specialized medical facilities. As a result of the dermatologists and other medical personnel who specialize in dermatology who work at these clinics, patients are certain to receive highly specialized treatment for their skin disorders. Moreover, the benefit of specialty clinics is that they provide a more specialized and thorough approach to Angular Cheilitis diagnosis and treatment. Dermatologists are skilled in correctly diagnosing the problem, locating its underlying causes, and creating treatment regimens that are unique to each patient. Additionally, they could have access to more advanced dermatological treatments and a wider variety of treatment alternatives. Therefore, these factors drive segment expansion.
Based on distribution channel, the global angular cheilitis treatment industry is bifurcated into hospital pharmacy, online pharmacy, and retail pharmacy.
|Report Attributes||Report Details|
|Report Name||Angular Cheilitis Treatment Market Report|
|Market Size in 2022||USD 2800 Million|
|Market Forecast in 2030||USD 4600 Million|
|Growth Rate||CAGR of 6.5%|
|Number of Pages||211|
|Key Companies Covered||Abbott, Cadila Pharmaceuticals, Novartis AG, Endo International Inc., Teva Pharmaceutical Industries Ltd, Cipla Inc, Dr Reddy's Laboratories Ltd, F. Hoffmann-La Roche Ltd, Pfizer Inc., Zydus Group, Lupin, Bayer AG, Torrent Pharmaceuticals Ltd, Lupin, Aurobindo Pharma, Hikma Pharmaceuticals PLC, Alkem Labs Ltd, Cosette Pharmaceuticals, GSK Plc., Amneal Pharmaceutical Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Perrigo Company plc and Akorn Operating Company LLC among others.|
|Segments Covered||By Diagnosis, By Treatment, By End User, By Distribution Channel, and By Region|
|Regions Covered||North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)|
|Historical Year||2017 to 2021|
|Forecast Year||2023 - 2030|
|Customization Scope||Avail customized purchase options to meet your exact research needs. Request For Customization|
North America is expected to dominate the market during the forecast period
North America is expected to dominate the global angular cheilitis treatment market over the forecast period. The market growth in the region is attributable to the growing older population and the increasing prevalence of diabetes. For instance, as per the United States Census Bureau, in the United States, 1 in 6 persons in 2020 were 65 or older. This percentage was less than 1 in 20 in 1920. From 4.9 million (or 4.7% of the total U.S. population) in 1920 to 55.8 million (16.8%) in 2020, the senior population rose by 50.9 million. In addition, according to the International Diabetes Federation, nearly 11% of Americans, or more than 34 million people, have diabetes. Thus, these factors drive the market growth in the region over the projected period.
The global Angular Cheilitis Treatment market is dominated by players like:
By End User
By Distribution Channel
An inflammation-related disorder that commonly affects the corners of the mouth or oral commissures is called angular cheilitis. It is also referred to as perleche (perlèche), cheilosis, angular stomatitis, and rhagades. At the angles of the mouth, where two different kinds of skin lining converge and serve as a hinge, angular cheilitis develops.
The angular cheilitis treatment market is expanding as a result of factors such as the rising prevalence of diabetes and increasing cases of these conditions. Moreover, retail pharmacies supply several treatments for angular cheilitis, and the rise in their number in highly developed nations creates several chances for market expansion. Additionally, due to their accessibility, people prefer to buy their medications from retail pharmacies.
According to the report, the global angular cheilitis treatment market size was worth around USD 2800 million in 2022 and is predicted to grow to around USD 4600 million by 2030.
The global Angular Cheilitis Treatment market is expected to grow at a CAGR of 6.5% during the forecast period.
The global Angular Cheilitis Treatment market growth is expected to be driven by North America. It is currently the world’s highest revenue-generating market due to the prevalence of diabetes and the rising geriatric population.
The global Angular Cheilitis Treatment market is dominated by players like Abbott, Cadila Pharmaceuticals, Novartis AG, Endo International Inc., Teva Pharmaceutical Industries Ltd, Cipla Inc, Dr Reddy's Laboratories Ltd, F. Hoffmann-La Roche Ltd, Pfizer Inc., Zydus Group, Lupin, Bayer AG, Torrent Pharmaceuticals Ltd, Lupin, Aurobindo Pharma, Hikma Pharmaceuticals PLC, Alkem Labs Ltd, Cosette Pharmaceuticals, GSK Plc., Amneal Pharmaceutical Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Perrigo Company plc and Akorn Operating Company LLC among others.